Mobile health technology integrated care in older atrial fibrillation patients: a subgroup analysis of the mAFA-II randomised clinical trial
Age and Ageing2022Vol. 51(11)
Citations Over TimeTop 10% of 2022 papers
Yutao Guo, Giulio Francesco Romiti, Marco Proietti, Niccolò Bonini, Hui Zhang, Gregory Y.H. Lip, the mAF-App II Trial Investigators, Deirdre A. Lane, Yundai Chen, Liming Wang, Jens Eckstein, G. Neil Thomas, Tong Liu, Mei Feng, Xuejun Liu, Xiaoming Li, Zhaoliang Shan, Shi Xiangming, Wei Zhang, Yunli Xing, Jing Wen, Fan Wu, Yang Sitong, Xiaoqing Jin, Yang Bo, Bai Xiao-juan, Yuting Jiang, Liu Yangxia, Yingying Song, Tan Zhongju, Yang Li, Tianzhu Luan, Niu Chunfeng, Lili Zhang, Shuyan Li, Zulu Wang, Xv Bing, Liu Liming, Yuan‐Zhe Jin, Yunlong Xia, Xiaohong Chen, Fang Wu, Lina Zhong, Sun Yihong, Jia Shujie, Jing Li, Nan Li, Shijun Li, Huixia Liu, Rong Li, Liu Fan, Ge Qingfeng, Guan Tianyun, Yuan Wen, Li Xin, Yan Ren, Xiaoping Chen, Ronghua Chen, Shi Yun, Yulan Zhao, Haili Shi, Yujie Zhao, Wang Quan-chun, Sun Weidong, Wei Lin
Abstract
A mHealth technology-implemented ABC pathway is effective in reducing adverse clinical outcomes in older AF patients. The benefits obtained with mAFA intervention were attenuated at extreme ages.
Related Papers
- → Stroke prevention in atrial fibrillation(2016)463 cited
- → Stroke in thyrotoxicosis with atrial fibrillation.(1988)179 cited
- → Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies(2018)52 cited
- → Incidence, clinical features and outcomes of atrial fibrillation and stroke in Qatar(2019)19 cited
- → Clinical Characteristics, Management, and Control of Permanent vs. Nonpermanent Atrial Fibrillation: Insights from the RealiseAF Survey(2014)11 cited